These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29233263)

  • 41. A broad overview of positron emission tomography radiopharmaceuticals and clinical applications: what is new?
    Vallabhajosula S; Solnes L; Vallabhajosula B
    Semin Nucl Med; 2011 Jul; 41(4):246-64. PubMed ID: 21624560
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Open for collaboration: an academic platform for drug discovery and development at SciLifeLab.
    Arvidsson PI; Sandberg K; Forsberg-Nilsson K
    Drug Discov Today; 2016 Oct; 21(10):1690-1698. PubMed ID: 27373760
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmaceutical industry, academia and patient advocacy organizations: what is the recipe for synergic (win-win-win) collaborations?
    Rose DM; Marshall R; Surber MW
    Respirology; 2015 Feb; 20(2):185-91. PubMed ID: 25580960
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomographic imaging in drug discovery.
    Ghosh KK; Padmanabhan P; Yang CT; Ng DCE; Palanivel M; Mishra S; Halldin C; Gulyás B
    Drug Discov Today; 2022 Jan; 27(1):280-291. PubMed ID: 34332093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A PET-compatible tissue bioreactor for research, discovery, and validation of imaging biomarkers and radiopharmaceuticals: system design and proof-of-concept studies.
    Whitehead TD; Nemanich ST; Dence C; Shoghi KI
    J Nucl Med; 2013 Oct; 54(10):1812-9. PubMed ID: 23978447
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pursuit of personalized anticancer therapy: leveraging collaboration between academia and the biotech/pharmaceutical industry.
    Buck E; Mulvihill M; Iwata KK
    Mt Sinai J Med; 2010; 77(4):358-65. PubMed ID: 20687181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Academic-industrial partnerships in drug discovery in the age of genomics.
    Harris T; Papadopoulos S; Goldstein DB
    Trends Biotechnol; 2015 Jun; 33(6):320-2. PubMed ID: 25987446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
    Barth V; Need A
    ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The academic-industrial complex: navigating the translational and cultural divide.
    Freedman S; Mullane K
    Drug Discov Today; 2017 Jul; 22(7):976-993. PubMed ID: 28336175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Imaging in drug development.
    Nairne J; Iveson PB; Meijer A
    Prog Med Chem; 2015; 54():231-80. PubMed ID: 25727706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The usefulness of radiotracers to make the body biochemically transparent.
    Johannsen B
    Amino Acids; 2005 Dec; 29(4):307-11. PubMed ID: 15924214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
    Slavik R; Müller Herde A; Haider A; Krämer SD; Weber M; Schibli R; Ametamey SM; Mu L
    J Neurochem; 2016 Sep; 138(6):874-86. PubMed ID: 27385045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electronic Generators for the Production of Positron-Emitter Labeled Radiopharmaceuticals. Where Would PET Be Without Them?
    Satyamurthy N; Phelps ME; Barrio JR
    Clin Positron Imaging; 1999 Oct; 2(5):233-253. PubMed ID: 14516648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies into radiolytic decomposition of fluorine-18 labeled radiopharmaceuticals for positron emission tomography.
    Scott PJ; Hockley BG; Kung HF; Manchanda R; Zhang W; Kilbourn MR
    Appl Radiat Isot; 2009 Jan; 67(1):88-94. PubMed ID: 18951032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and Preclinical Evaluation of Three Novel Fluorine-18 Labeled Radiopharmaceuticals for P-Glycoprotein PET Imaging at the Blood-Brain Barrier.
    Savolainen H; Cantore M; Colabufo NA; Elsinga PH; Windhorst AD; Luurtsema G
    Mol Pharm; 2015 Jul; 12(7):2265-75. PubMed ID: 26043236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Academic-Pharma drug discovery alliances: seeking ways to eliminate the valley of death.
    Hammonds T
    Future Med Chem; 2015; 7(14):1891-9. PubMed ID: 26393391
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptor.
    Jackson A; Guilbert BB; Plant SD; Goggi J; Battle MR; Woodcraft JL; Gaeta A; Jones CL; Bouvet DR; Jones PA; O'Shea DM; Zheng PH; Brown SL; Ewan AL; Trigg W
    Bioorg Med Chem Lett; 2013 Feb; 23(3):821-6. PubMed ID: 23265897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Boron reagents for divergent radiochemistry.
    Wilson TC; Cailly T; Gouverneur V
    Chem Soc Rev; 2018 Sep; 47(18):6990-7005. PubMed ID: 30140795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.